Back
iShares International Equity Factor ETF Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Buy
57
INTF
iShares International Equity Factor ETF
Last Price:
$37.26
Seasonality Move:
-2.16%
Buy
65
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$112.41
Seasonality Move:
-9.01%
Buy
57
iShares International Equity Factor ETF (INTF)
is a Buy
Is iShares International Equity Factor ETF a Buy, Sell or Hold?
-
The current iShares International Equity Factor ETF [INTF] share price is $37.99. The Score for INTF is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
INTF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Buy
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $112.52. The Score for RYTM is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
INTF Stock Price Chart
What is iShares International Equity Factor ETF's stock price today?
-
The iShares International Equity Factor ETF share price today is $37.99The current trend is moderately bullish and INTF is experiencing slight buying pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $112.52Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing selling pressure, which indicates risk of future bearish movement.
INTF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 67.46 | Buy |
| Chaikin Money Flow: | 92569 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.25 - 37.53) | Buy |
| Bollinger Bands (100): | (35.08 - 36.84) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.96 | Buy |
| Relative Strength Index (14 RSI): | 58.01 | Buy |
| Chaikin Money Flow: | -777320 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (99.06 - 109.34) | Buy |
| Bollinger Bands (100): | (94.22 - 108.04) | Buy |
INTF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.53 | Buy |
| 20-day SMA: | 36.89 | Buy |
| 50-day SMA: | 36.57 | Buy |
| 200-day SMA: | 34.23 | Buy |
| 8-day EMA: | 37.56 | Buy |
| 20-day EMA: | 37.13 | Buy |
| 50-day EMA: | 35.92 | Buy |
| 200-day EMA: | 22.48 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 108.08 | Buy |
| 20-day SMA: | 105.72 | Buy |
| 50-day SMA: | 105.41 | Buy |
| 200-day SMA: | 82.03 | Buy |
| 8-day EMA: | 109.43 | Buy |
| 20-day EMA: | 106.76 | Buy |
| 50-day EMA: | 104.27 | Buy |
| 200-day EMA: | 86.91 | Buy |
iShares International Equity Factor ETF Earnings Growth & INTF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.
iShares International Equity Factor ETF Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||